Toxic Alcohols Exam 3 Flashcards

1
Q

Toxic effects of TCA’s

A
  • QRS widening
  • dysrhythmias
  • seizures (can be controlled)
  • CNS effects
  • myocardium effects
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Toxicity of TCA’s in relation to QRS widening

A
  • QRS > 100 msec, 1/3 of patients had seizures
  • QRS > 160 msec, 1/2 of patients had ventricular dysrhythmias
  • QRS < 100 msec, no significant toxicity
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Toxic effects of TCA’s: CNS effects

A

Anticholinergic effects

  • Hot as a hare (hyperthermia)
  • Dry as a bone (dry skin)
  • Red as a beet (flushed)
  • Blind as bat (mydriasis)
  • Mad as a hatter (delirium)

Central anticholinergic effects include

  • Agitation, excitability
  • Lethargy
  • Hallucinations
  • Hyperthermia
  • Ataxia
  • Choreoathetoid movements
  • Seizures
  • Coma

Other anticholinergic effects

  • Tachycardia
  • Dilated pupils
  • Dry flushed skin
  • Decreased GI motility
  • Urinary retention
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Toxic effects of TCA’s: seizures

A
  • happens shortly after duration
  • brief and resolves itself
  • If persistent must be controlled to prevent hypoxia and lactic acidosis, both of which may predispose to life-threatening ventricular dysrhythmias
  • Patients with protracted seizures are also at risk for developing rhabdomyolysis and acute renal failure
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Toxic effects of TCA’s: myocardium effects

A
  • TCAs block myocardial sodium channels, resulting in a membrane depressant effect on the heart; increased threshold for excitability.
  • Also block potassium channels which further prolongs action potential duration in most cardiac cells
  • Classic sign of TCA toxicity is prolongation of the QRS complex
  • Hypertension ( caused by release of NE) or hypotension
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Toxic effects of TCA’s: hypotension

A

Caused by

  • Negative inotropic effects of TCAs
  • Potent alpha-adrenergic antagonist effects, which results in decreased peripheral vascular resistance
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Treatment of TCA toxicity

A
  • ABCs
  • Decontamination: activated charcoal (1-2g/kg body weight)
  • BZDs for seizures; if doesn’t work -> consider barbiturates or propofol; if doesn’t work -> NMB and general anesthesia; DO NOT USE PHENYTOIN
  • Hypotension: IV fluids; 10-30mL/kg of LR or NS; if doesn’t work -> vasopressors (NE); DO NOT USE DOPAMINE
  • Dysrhythmias: bicarb, hyperventilation (can lead to resp. alkalosis), hypertonic saline (if pt also have hypotension but rarely used)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Treatment of TCA toxicity: dysrhythmias

A
  • Sodium bicarbonate
  • Start bicarb immediately if QRS widening to 100 msec or greater is noted
  • Hypotension is also an indication for alkalization, as it has responded to bicarb administration in experimental models
  • No evidence to support a role for bicarb in TCA poisoning in patients who present with altered mental status without QRS widening or hypotension
  • Sodium bicarbonate reverses the quinidine-like effects that produce the major, life-threatening CV manifestations of TCA overdose
  • 1-2 mEq/kg administered IV as a bolus over 1-2 minutes. Larger doses may be required for unstable ventricular dysrhythmias
  • Repeat PRN to achieve pH of 7.45-7.55
  • Continuous infusion – add 1-3 50 mL ampules to liter of IVF and run at maintenance or more than maintenance, depending on fluid requirements and BP of patient
  • Administer over 4-6 hours, maintaining pH at target level.
  • infusion may be DCd if width of QRS complex remains less than 100 msec without administration of sodium bicarbonate
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What should you avoid when treataing TCA toxicity: dysrhythmias

A

AVOID all IA and IC antidysrhythmics -> worsen hypotension and cardiotoxicity

  • quinidine
  • procainamide
  • disopyramide
  • flecainide
  • encainide
  • propafenone

Beta blockers and calcium channel blockers are dangerous for patients with wide-complex dysrhythmias, as they slow conduction velocity, decrease heart rate, and lower blood pressure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Patient disposition: TCA toxicity

A
  • Admit any patient with QRS interval of >100 msec
  • Admit any patient who has experienced a seizure
  • Admit any patient in need of psychiatric or medical support
  • Most patients with ECG abnormalities should be placed in the ICU for minimum of 12-24 hours
  • Patients who have been decontaminated, who never seize or develop abnormal ECGs (other than sinus tachycardia) can be safely discharged after six hours of observation if otherwise stable
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

SSRI overdose effects

A
  • nausea
  • vomiting
  • lethargy
  • sedation
  • possible serotonin syndrome
  • QTc prolongation and seizures with Celexa
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Hunter serotonin toxicity criteria

A

Any ‘yes’ decision to any of the following decision rules suggests definite or significant serotonin toxicity:

  • If the patient has spontaneous clonus.
  • If the patient has inducible clonus AND agitation OR diaphoresis.
  • If the patient has ocular clonus AND agitation OR diaphoresis.
  • If the patient has tremor AND hyperreflexia.
  • If the patient is hypertonic AND has a temperature greater 38 degrees C AND ocular clonus OR inducible clonus.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

serotonin syndrome

A
  • mental status changes
  • agitation
  • myoclonus
  • hyperreflexia
  • diaphoresis
  • shivering
  • tremor
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Treatment of SSRI overdose

A
  • Administration of activated charcoal
  • Rule out co-ingestants (ECG, drug screen, APAP level)
  • Treatment is primarily symptomatic and supportive care
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Treatment of serotonin syndrome

A
  • For mild cases, consider use of cyproheptadine (Periactin)
  • Adult dose: 12 milligrams orally initially, followed by 2 milligrams every 2 hours if symptoms persist. Max of 32 milligrams may be administered in 24 hours
  • Pediatric dose: 0.25 milligrams/kilogram/day divided every 6 hours, maximum dose 12 milligrams/day
  • Benzodiazepines for sedation, hydration, and external cooling are important to help prevent progression to severe toxicity
  • For severe toxicity elective intubation, neuromuscular paralysis, mechanical ventilation, and aggressive cooling measures are indicated
  • Benzodiazepines for sedation, hydration, and external cooling are important to help prevent progression to severe toxicity
  • For severe toxicity elective intubation, neuromuscular paralysis, mechanical ventilation, and aggressive cooling measures are indicated
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Toxic effects of MAOIs

A
  • Hypertension
  • Tachycardia
  • Agitation
  • Delirium or obtundation
  • Nystagmus
  • Hyperreflexia
  • Tremor
  • Myoclonus
  • Muscle rigidity
  • Seizures
  • Hyperthermia
  • Tachypnea
  • Respiratory depression
  • Cardiovascular collapse, hypotension
17
Q

Treatment of MAOI toxicity

A
  • ABCs
  • Gastric decontamination – activated charcoal
  • Treat hypertension with phentolamine (Regitine) as first-line agent. Monitor blood pressure closely because of the possibility of cardiovascular collapse and hypotension
  • Treat hypotension with IV fluid (10-20 mL/kg of NS), given as a bolus. Vasopressors may be required
  • Seizures should be treated using benzodiazepines as the first-line agent
  • Treat hyperthermia with aggressive external cooling
  • Signs and symptoms of serotonin syndrome should be treated as for SSRIs
  • Patients with intentional ingestion of a potentially toxic dose of an MAOI should be observed in a monitored setting for 24 hours due to potential for delayed onset of toxicity
18
Q

Toxicity of antidepressants

A
  • sedation

- seizures

19
Q

Treatment of antidepressants intoxication

A
  • Treatment consist primarily of gastric decontamination (activated charcoal), followed by symptomatic and supportive care
  • Treatment of seizure activity due to these agents is use of benzodiazepines as first-line agents, with barbiturates for refractory seizures
20
Q

Toxicity

A
  • sedation, hypotension, tachycardia, and anticholinergic effects
  • Dysrhythmias and seizures may be seen in more severe cases
  • Prolongation of the QT interval is more common with the atypical neuroleptics
  • Absorption of these drugs is rapid, and toxic effects are usually seen early (within four to six hours)
21
Q

Treatment of neuroleptic overdose

A

ABCs are paramount

22
Q

Decontamination of neuroleptic overdose

A

Administer activated charcoal

23
Q

neuroleptic overdose: treatment of acute dystonic reactions

A
  • Diphenhydramine (Benadryl) 1 mg/kg IV, continue oral dosing for two to three days

or

  • Benztropine (Cogentin) 1-2 mg IM or IV, followed by regular PO dosing (2-8 mg/day in divided doses) for persistent dystonia
24
Q

Neuroleptic malignant syndrome

A
  • A life-threatening condition characterized by fever, rigidity, altered sensorium, and autonomic dysfunction (sweating, tachycardia, labile blood pressure, and tachypnea)
  • Treatment primarily consists of supportive care, with withdrawal of the offending drug
  • Intravenous benzodiazepines are helpful in controlling muscle rigidity and minimizing potential rhabdomyolysis
  • Consider PO bromocriptine in patients who are able to swallow. Significant clinical improvement may not be seen for 24-72 hours
    + Adult dose: 5 milligrams orally three times a day; if response is inadequate, increase dose rapidly to a maximum of 20 milligrams orally every six hours
    + Continue for up to seven days, until patient’s condition improves clinically or until creatine kinase levels return to normal. Then, withdraw slowly over additional three days. Early discontinuation may result in relapse.
    + Dantrolene has been used with varying success
25
Q

Symptoms with ACUTE lithium toxicity

A
  • Cardiovascular: Prolonged QT, ST & T wave abnormalities
  • Renal: Concentrating defects
  • Mild: Weakness, light-headedness, fine tremor
  • Moderate: Muscle twitching, tinnitus, drowsiness, hyperreflexia, slurred speech, apathy
  • Severe: Confusion, clonus, coma, seizures
  • Gastrointestinal: Nausea and vomiting
26
Q

Symptoms with CHRONIC lithium toxicity

A
    • Cardiovascular: Myocarditis
  • Cutaneous: Dermatitis, ulcers, localized edema
  • Renal: Nephrogenic diabetes insipidus
  • Neurologic: Mild
  • Moderate: Muscle twitching, tinnitus, drowsiness, hyperreflexia, slurred speech, apathy
  • Severe: Parkinson’s disease, psychosis, memory deficits
  • Gastrointestinal Minimal effects
  • Endocrine: Hypothyroidism
27
Q

Signs and symptoms of CHRONIC lithium toxicity, with associated serum levels

A
  • > 1.5 mEq/L: Nausea, malaise, weakness
  • > 2 mEq/L: Increased fatigue and somnolence, confusion, slurred speech, nystagmus
  • > 2.5 mEq/L: Increasing confusion, ataxia, myoclonic movements, choreoathetosis, restlessness
  • > 3mEq/L: Coma, seizures, circulatory collapse
28
Q

Treatment of lithium intoxication

A
  • ABCs
  • Lavage controversial, but may be of benefit in recent, large ingestions; Large tablet size and relative insolubility of sustained-release preparations may limit the effectiveness of gastric lavage
  • Once the patient has been stabilized, consider enhanced GI clearance by the initiation of whole bowel irrigation. This is particularly important if sustained-release preparations have been ingested